The changing landscape of drug clinical trials on cardiometabolic diseases in China, 2009 –2021
Cardiometabolic disease is a clinical syndrome characterized by multiple metabolic disorders, with atherosclerosis as the core and cardiovascular and cerebrovascular events as the outcome. Drug research and de...
Source: Diabetology and Metabolic Syndrome - Category: Endocrinology Authors: Chen Li, Jun Hao, Yitian Zheng, Chuangshi Wang, Jie Yang, Wenyao Wang, Kuo Zhang, Chunli Shao, Wen Hui, Jiancheng Wang, Wei Li and Yi-Da Tang Tags: Research Source Type: research
More News: Cardiology | Cardiovascular | China Health | Clinical Trials | Endocrinology | Heart | Metabolic Syndrome